Global Crude Heparin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Crude Heparin market size is predicted to grow from US$ 3561 million in 2025 to US$ 4866 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
LP Information, Inc. (LPI) ' newest research report, the “Crude Heparin Industry Forecast” looks at past sales and reviews total world Crude Heparin sales in 2024, providing a comprehensive analysis by region and market sector of projected Crude Heparin sales for 2025 through 2031. With Crude Heparin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crude Heparin industry.
This Insight Report provides a comprehensive analysis of the global Crude Heparin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crude Heparin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Crude Heparin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crude Heparin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crude Heparin.
This report presents a comprehensive overview, market shares, and growth opportunities of Crude Heparin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Crude Heparin market?
What factors are driving Crude Heparin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Crude Heparin market opportunities vary by end market size?
How does Crude Heparin break out by Type, by Application?
The global Crude Heparin market size is predicted to grow from US$ 3561 million in 2025 to US$ 4866 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
LP Information, Inc. (LPI) ' newest research report, the “Crude Heparin Industry Forecast” looks at past sales and reviews total world Crude Heparin sales in 2024, providing a comprehensive analysis by region and market sector of projected Crude Heparin sales for 2025 through 2031. With Crude Heparin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Crude Heparin industry.
This Insight Report provides a comprehensive analysis of the global Crude Heparin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Crude Heparin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Crude Heparin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Crude Heparin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Crude Heparin.
This report presents a comprehensive overview, market shares, and growth opportunities of Crude Heparin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
- UFH
- LMWH
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
What is the 10-year outlook for the global Crude Heparin market?
What factors are driving Crude Heparin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Crude Heparin market opportunities vary by end market size?
How does Crude Heparin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Crude Heparin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Crude Heparin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Crude Heparin by Country/Region, 2020, 2024 & 2031
2.2 Crude Heparin Segment by Type
2.2.1 Pig Intestine Mucosa Heparin
2.2.2 Bovine Heparin and Others
2.3 Crude Heparin Sales by Type
2.3.1 Global Crude Heparin Sales Market Share by Type (2020-2025)
2.3.2 Global Crude Heparin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Crude Heparin Sale Price by Type (2020-2025)
2.4 Crude Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Crude Heparin Sales by Application
2.5.1 Global Crude Heparin Sale Market Share by Application (2020-2025)
2.5.2 Global Crude Heparin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Crude Heparin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Crude Heparin Breakdown Data by Company
3.1.1 Global Crude Heparin Annual Sales by Company (2020-2025)
3.1.2 Global Crude Heparin Sales Market Share by Company (2020-2025)
3.2 Global Crude Heparin Annual Revenue by Company (2020-2025)
3.2.1 Global Crude Heparin Revenue by Company (2020-2025)
3.2.2 Global Crude Heparin Revenue Market Share by Company (2020-2025)
3.3 Global Crude Heparin Sale Price by Company
3.4 Key Manufacturers Crude Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crude Heparin Product Location Distribution
3.4.2 Players Crude Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CRUDE HEPARIN BY GEOGRAPHIC REGION
4.1 World Historic Crude Heparin Market Size by Geographic Region (2020-2025)
4.1.1 Global Crude Heparin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Crude Heparin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Crude Heparin Market Size by Country/Region (2020-2025)
4.2.1 Global Crude Heparin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Crude Heparin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Crude Heparin Sales Growth
4.4 APAC Crude Heparin Sales Growth
4.5 Europe Crude Heparin Sales Growth
4.6 Middle East & Africa Crude Heparin Sales Growth
5 AMERICAS
5.1 Americas Crude Heparin Sales by Country
5.1.1 Americas Crude Heparin Sales by Country (2020-2025)
5.1.2 Americas Crude Heparin Revenue by Country (2020-2025)
5.2 Americas Crude Heparin Sales by Type (2020-2025)
5.3 Americas Crude Heparin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crude Heparin Sales by Region
6.1.1 APAC Crude Heparin Sales by Region (2020-2025)
6.1.2 APAC Crude Heparin Revenue by Region (2020-2025)
6.2 APAC Crude Heparin Sales by Type (2020-2025)
6.3 APAC Crude Heparin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Crude Heparin by Country
7.1.1 Europe Crude Heparin Sales by Country (2020-2025)
7.1.2 Europe Crude Heparin Revenue by Country (2020-2025)
7.2 Europe Crude Heparin Sales by Type (2020-2025)
7.3 Europe Crude Heparin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Crude Heparin by Country
8.1.1 Middle East & Africa Crude Heparin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Crude Heparin Revenue by Country (2020-2025)
8.2 Middle East & Africa Crude Heparin Sales by Type (2020-2025)
8.3 Middle East & Africa Crude Heparin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crude Heparin
10.3 Manufacturing Process Analysis of Crude Heparin
10.4 Industry Chain Structure of Crude Heparin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crude Heparin Distributors
11.3 Crude Heparin Customer
12 WORLD FORECAST REVIEW FOR CRUDE HEPARIN BY GEOGRAPHIC REGION
12.1 Global Crude Heparin Market Size Forecast by Region
12.1.1 Global Crude Heparin Forecast by Region (2026-2031)
12.1.2 Global Crude Heparin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Crude Heparin Forecast by Type (2026-2031)
12.7 Global Crude Heparin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bioiberica
13.1.1 Bioiberica Company Information
13.1.2 Bioiberica Crude Heparin Product Portfolios and Specifications
13.1.3 Bioiberica Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bioiberica Main Business Overview
13.1.5 Bioiberica Latest Developments
13.2 Shenzhen Hepalink
13.2.1 Shenzhen Hepalink Company Information
13.2.2 Shenzhen Hepalink Crude Heparin Product Portfolios and Specifications
13.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shenzhen Hepalink Main Business Overview
13.2.5 Shenzhen Hepalink Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Crude Heparin Product Portfolios and Specifications
13.3.3 Sanofi Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Nanjing King-friend
13.4.1 Nanjing King-friend Company Information
13.4.2 Nanjing King-friend Crude Heparin Product Portfolios and Specifications
13.4.3 Nanjing King-friend Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nanjing King-friend Main Business Overview
13.4.5 Nanjing King-friend Latest Developments
13.5 Fengrun Biological Technology
13.5.1 Fengrun Biological Technology Company Information
13.5.2 Fengrun Biological Technology Crude Heparin Product Portfolios and Specifications
13.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fengrun Biological Technology Main Business Overview
13.5.5 Fengrun Biological Technology Latest Developments
13.6 Aspen Oss
13.6.1 Aspen Oss Company Information
13.6.2 Aspen Oss Crude Heparin Product Portfolios and Specifications
13.6.3 Aspen Oss Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Aspen Oss Main Business Overview
13.6.5 Aspen Oss Latest Developments
13.7 Hebei Changshan Biochemical
13.7.1 Hebei Changshan Biochemical Company Information
13.7.2 Hebei Changshan Biochemical Crude Heparin Product Portfolios and Specifications
13.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hebei Changshan Biochemical Main Business Overview
13.7.5 Hebei Changshan Biochemical Latest Developments
13.8 Changzhou Qianhong
13.8.1 Changzhou Qianhong Company Information
13.8.2 Changzhou Qianhong Crude Heparin Product Portfolios and Specifications
13.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changzhou Qianhong Main Business Overview
13.8.5 Changzhou Qianhong Latest Developments
13.9 Hepac (Darling Ingredients)
13.9.1 Hepac (Darling Ingredients) Company Information
13.9.2 Hepac (Darling Ingredients) Crude Heparin Product Portfolios and Specifications
13.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hepac (Darling Ingredients) Main Business Overview
13.9.5 Hepac (Darling Ingredients) Latest Developments
13.10 Huaian MDC Pharmaceutical
13.10.1 Huaian MDC Pharmaceutical Company Information
13.10.2 Huaian MDC Pharmaceutical Crude Heparin Product Portfolios and Specifications
13.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Huaian MDC Pharmaceutical Main Business Overview
13.10.5 Huaian MDC Pharmaceutical Latest Developments
13.11 Yantai Dongcheng Biochemicals
13.11.1 Yantai Dongcheng Biochemicals Company Information
13.11.2 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolios and Specifications
13.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Yantai Dongcheng Biochemicals Main Business Overview
13.11.5 Yantai Dongcheng Biochemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Crude Heparin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Crude Heparin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pig Intestine Mucosa Heparin
Table 4. Major Players of Bovine Heparin and Others
Table 5. Global Crude Heparin Sales byType (2020-2025) & (Tons)
Table 6. Global Crude Heparin Sales Market Share byType (2020-2025)
Table 7. Global Crude Heparin Revenue byType (2020-2025) & ($ million)
Table 8. Global Crude Heparin Revenue Market Share byType (2020-2025)
Table 9. Global Crude Heparin Sale Price byType (2020-2025) & (US$/Kg)
Table 10. Global Crude Heparin Sale by Application (2020-2025) & (Tons)
Table 11. Global Crude Heparin Sale Market Share by Application (2020-2025)
Table 12. Global Crude Heparin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Crude Heparin Revenue Market Share by Application (2020-2025)
Table 14. Global Crude Heparin Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 16. Global Crude Heparin Sales Market Share by Company (2020-2025)
Table 17. Global Crude Heparin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Crude Heparin Revenue Market Share by Company (2020-2025)
Table 19. Global Crude Heparin Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Crude Heparin Producing Area Distribution and Sales Area
Table 21. Players Crude Heparin Products Offered
Table 22. Crude Heparin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Crude Heparin Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Crude Heparin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Crude Heparin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Crude Heparin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Crude Heparin Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Crude Heparin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Crude Heparin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Crude Heparin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 34. Americas Crude Heparin Sales Market Share by Country (2020-2025)
Table 35. Americas Crude Heparin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Crude Heparin Sales byType (2020-2025) & (Tons)
Table 37. Americas Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 38. APAC Crude Heparin Sales by Region (2020-2025) & (Tons)
Table 39. APAC Crude Heparin Sales Market Share by Region (2020-2025)
Table 40. APAC Crude Heparin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Crude Heparin Sales byType (2020-2025) & (Tons)
Table 42. APAC Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 43. Europe Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 44. Europe Crude Heparin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Crude Heparin Sales byType (2020-2025) & (Tons)
Table 46. Europe Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Crude Heparin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Crude Heparin Sales byType (2020-2025) & (Tons)
Table 50. Middle East & Africa Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Crude Heparin
Table 52. Key Market Challenges & Risks of Crude Heparin
Table 53. Key IndustryTrends of Crude Heparin
Table 54. Crude Heparin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Crude Heparin Distributors List
Table 57. Crude Heparin Customer List
Table 58. Global Crude Heparin SalesForecast by Region (2026-2031) & (Tons)
Table 59. Global Crude Heparin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 61. Americas Crude Heparin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Crude Heparin SalesForecast by Region (2026-2031) & (Tons)
Table 63. APAC Crude Heparin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 65. Europe Crude Heparin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Crude Heparin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Crude Heparin SalesForecast byType (2026-2031) & (Tons)
Table 69. Global Crude Heparin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Crude Heparin SalesForecast by Application (2026-2031) & (Tons)
Table 71. Global Crude Heparin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Bioiberica Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 73. Bioiberica Crude Heparin Product Portfolios and Specifications
Table 74. Bioiberica Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Bioiberica Main Business
Table 76. Bioiberica Latest Developments
Table 77. Shenzhen Hepalink Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 78. Shenzhen Hepalink Crude Heparin Product Portfolios and Specifications
Table 79. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Shenzhen Hepalink Main Business
Table 81. Shenzhen Hepalink Latest Developments
Table 82. Sanofi Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Crude Heparin Product Portfolios and Specifications
Table 84. Sanofi Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Nanjing King-friend Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 88. Nanjing King-friend Crude Heparin Product Portfolios and Specifications
Table 89. Nanjing King-friend Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Nanjing King-friend Main Business
Table 91. Nanjing King-friend Latest Developments
Table 92.Fengrun BiologicalTechnology Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 93.Fengrun BiologicalTechnology Crude Heparin Product Portfolios and Specifications
Table 94.Fengrun BiologicalTechnology Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95.Fengrun BiologicalTechnology Main Business
Table 96.Fengrun BiologicalTechnology Latest Developments
Table 97. Aspen Oss Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 98. Aspen Oss Crude Heparin Product Portfolios and Specifications
Table 99. Aspen Oss Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Aspen Oss Main Business
Table 101. Aspen Oss Latest Developments
Table 102. Hebei Changshan Biochemical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 103. Hebei Changshan Biochemical Crude Heparin Product Portfolios and Specifications
Table 104. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Hebei Changshan Biochemical Main Business
Table 106. Hebei Changshan Biochemical Latest Developments
Table 107. Changzhou Qianhong Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 108. Changzhou Qianhong Crude Heparin Product Portfolios and Specifications
Table 109. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Changzhou Qianhong Main Business
Table 111. Changzhou Qianhong Latest Developments
Table 112. Hepac (Darling Ingredients) Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 113. Hepac (Darling Ingredients) Crude Heparin Product Portfolios and Specifications
Table 114. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Hepac (Darling Ingredients) Main Business
Table 116. Hepac (Darling Ingredients) Latest Developments
Table 117. Huaian MDC Pharmaceutical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 118. Huaian MDC Pharmaceutical Crude Heparin Product Portfolios and Specifications
Table 119. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Huaian MDC Pharmaceutical Main Business
Table 121. Huaian MDC Pharmaceutical Latest Developments
Table 122. Yantai Dongcheng Biochemicals Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 123. Yantai Dongcheng Biochemicals Crude Heparin Product Portfolios and Specifications
Table 124. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Yantai Dongcheng Biochemicals Main Business
Table 126. Yantai Dongcheng Biochemicals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Crude Heparin
Figure 2. Crude Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crude Heparin Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Crude Heparin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Crude Heparin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Crude Heparin Sales Market Share by Country/Region (2024)
Figure 10. Crude Heparin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pig Intestine Mucosa Heparin
Figure 12. Product Picture of Bovine Heparin and Others
Figure 13. Global Crude Heparin Sales Market Share byType in 2025
Figure 14. Global Crude Heparin Revenue Market Share byType (2020-2025)
Figure 15. Crude Heparin Consumed in UFH
Figure 16. Global Crude Heparin Market: UFH (2020-2025) & (Tons)
Figure 17. Crude Heparin Consumed in LMWH
Figure 18. Global Crude Heparin Market: LMWH (2020-2025) & (Tons)
Figure 19. Global Crude Heparin Sale Market Share by Application (2024)
Figure 20. Global Crude Heparin Revenue Market Share by Application in 2025
Figure 21. Crude Heparin Sales by Company in 2025 (Tons)
Figure 22. Global Crude Heparin Sales Market Share by Company in 2025
Figure 23. Crude Heparin Revenue by Company in 2025 ($ millions)
Figure 24. Global Crude Heparin Revenue Market Share by Company in 2025
Figure 25. Global Crude Heparin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Crude Heparin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Crude Heparin Sales 2020-2025 (Tons)
Figure 28. Americas Crude Heparin Revenue 2020-2025 ($ millions)
Figure 29. APAC Crude Heparin Sales 2020-2025 (Tons)
Figure 30. APAC Crude Heparin Revenue 2020-2025 ($ millions)
Figure 31. Europe Crude Heparin Sales 2020-2025 (Tons)
Figure 32. Europe Crude Heparin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Crude Heparin Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Crude Heparin Revenue 2020-2025 ($ millions)
Figure 35. Americas Crude Heparin Sales Market Share by Country in 2025
Figure 36. Americas Crude Heparin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Crude Heparin Sales Market Share byType (2020-2025)
Figure 38. Americas Crude Heparin Sales Market Share by Application (2020-2025)
Figure 39. United States Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Crude Heparin Sales Market Share by Region in 2025
Figure 44. APAC Crude Heparin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Crude Heparin Sales Market Share byType (2020-2025)
Figure 46. APAC Crude Heparin Sales Market Share by Application (2020-2025)
Figure 47. China Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Crude Heparin Sales Market Share by Country in 2025
Figure 55. Europe Crude Heparin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Crude Heparin Sales Market Share byType (2020-2025)
Figure 57. Europe Crude Heparin Sales Market Share by Application (2020-2025)
Figure 58. Germany Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 59.France Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Crude Heparin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Crude Heparin Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Crude Heparin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Crude Heparin in 2025
Figure 72. Manufacturing Process Analysis of Crude Heparin
Figure 73. Industry Chain Structure of Crude Heparin
Figure 74. Channels of Distribution
Figure 75. Global Crude Heparin Sales MarketForecast by Region (2026-2031)
Figure 76. Global Crude Heparin Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Crude Heparin Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Crude Heparin Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Crude Heparin Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Crude Heparin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Crude Heparin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Crude Heparin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Crude Heparin by Country/Region, 2020, 2024 & 2031
2.2 Crude Heparin Segment by Type
2.2.1 Pig Intestine Mucosa Heparin
2.2.2 Bovine Heparin and Others
2.3 Crude Heparin Sales by Type
2.3.1 Global Crude Heparin Sales Market Share by Type (2020-2025)
2.3.2 Global Crude Heparin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Crude Heparin Sale Price by Type (2020-2025)
2.4 Crude Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Crude Heparin Sales by Application
2.5.1 Global Crude Heparin Sale Market Share by Application (2020-2025)
2.5.2 Global Crude Heparin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Crude Heparin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Crude Heparin Breakdown Data by Company
3.1.1 Global Crude Heparin Annual Sales by Company (2020-2025)
3.1.2 Global Crude Heparin Sales Market Share by Company (2020-2025)
3.2 Global Crude Heparin Annual Revenue by Company (2020-2025)
3.2.1 Global Crude Heparin Revenue by Company (2020-2025)
3.2.2 Global Crude Heparin Revenue Market Share by Company (2020-2025)
3.3 Global Crude Heparin Sale Price by Company
3.4 Key Manufacturers Crude Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crude Heparin Product Location Distribution
3.4.2 Players Crude Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CRUDE HEPARIN BY GEOGRAPHIC REGION
4.1 World Historic Crude Heparin Market Size by Geographic Region (2020-2025)
4.1.1 Global Crude Heparin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Crude Heparin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Crude Heparin Market Size by Country/Region (2020-2025)
4.2.1 Global Crude Heparin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Crude Heparin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Crude Heparin Sales Growth
4.4 APAC Crude Heparin Sales Growth
4.5 Europe Crude Heparin Sales Growth
4.6 Middle East & Africa Crude Heparin Sales Growth
5 AMERICAS
5.1 Americas Crude Heparin Sales by Country
5.1.1 Americas Crude Heparin Sales by Country (2020-2025)
5.1.2 Americas Crude Heparin Revenue by Country (2020-2025)
5.2 Americas Crude Heparin Sales by Type (2020-2025)
5.3 Americas Crude Heparin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crude Heparin Sales by Region
6.1.1 APAC Crude Heparin Sales by Region (2020-2025)
6.1.2 APAC Crude Heparin Revenue by Region (2020-2025)
6.2 APAC Crude Heparin Sales by Type (2020-2025)
6.3 APAC Crude Heparin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Crude Heparin by Country
7.1.1 Europe Crude Heparin Sales by Country (2020-2025)
7.1.2 Europe Crude Heparin Revenue by Country (2020-2025)
7.2 Europe Crude Heparin Sales by Type (2020-2025)
7.3 Europe Crude Heparin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Crude Heparin by Country
8.1.1 Middle East & Africa Crude Heparin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Crude Heparin Revenue by Country (2020-2025)
8.2 Middle East & Africa Crude Heparin Sales by Type (2020-2025)
8.3 Middle East & Africa Crude Heparin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crude Heparin
10.3 Manufacturing Process Analysis of Crude Heparin
10.4 Industry Chain Structure of Crude Heparin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crude Heparin Distributors
11.3 Crude Heparin Customer
12 WORLD FORECAST REVIEW FOR CRUDE HEPARIN BY GEOGRAPHIC REGION
12.1 Global Crude Heparin Market Size Forecast by Region
12.1.1 Global Crude Heparin Forecast by Region (2026-2031)
12.1.2 Global Crude Heparin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Crude Heparin Forecast by Type (2026-2031)
12.7 Global Crude Heparin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bioiberica
13.1.1 Bioiberica Company Information
13.1.2 Bioiberica Crude Heparin Product Portfolios and Specifications
13.1.3 Bioiberica Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bioiberica Main Business Overview
13.1.5 Bioiberica Latest Developments
13.2 Shenzhen Hepalink
13.2.1 Shenzhen Hepalink Company Information
13.2.2 Shenzhen Hepalink Crude Heparin Product Portfolios and Specifications
13.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Shenzhen Hepalink Main Business Overview
13.2.5 Shenzhen Hepalink Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Crude Heparin Product Portfolios and Specifications
13.3.3 Sanofi Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Nanjing King-friend
13.4.1 Nanjing King-friend Company Information
13.4.2 Nanjing King-friend Crude Heparin Product Portfolios and Specifications
13.4.3 Nanjing King-friend Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Nanjing King-friend Main Business Overview
13.4.5 Nanjing King-friend Latest Developments
13.5 Fengrun Biological Technology
13.5.1 Fengrun Biological Technology Company Information
13.5.2 Fengrun Biological Technology Crude Heparin Product Portfolios and Specifications
13.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fengrun Biological Technology Main Business Overview
13.5.5 Fengrun Biological Technology Latest Developments
13.6 Aspen Oss
13.6.1 Aspen Oss Company Information
13.6.2 Aspen Oss Crude Heparin Product Portfolios and Specifications
13.6.3 Aspen Oss Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Aspen Oss Main Business Overview
13.6.5 Aspen Oss Latest Developments
13.7 Hebei Changshan Biochemical
13.7.1 Hebei Changshan Biochemical Company Information
13.7.2 Hebei Changshan Biochemical Crude Heparin Product Portfolios and Specifications
13.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hebei Changshan Biochemical Main Business Overview
13.7.5 Hebei Changshan Biochemical Latest Developments
13.8 Changzhou Qianhong
13.8.1 Changzhou Qianhong Company Information
13.8.2 Changzhou Qianhong Crude Heparin Product Portfolios and Specifications
13.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changzhou Qianhong Main Business Overview
13.8.5 Changzhou Qianhong Latest Developments
13.9 Hepac (Darling Ingredients)
13.9.1 Hepac (Darling Ingredients) Company Information
13.9.2 Hepac (Darling Ingredients) Crude Heparin Product Portfolios and Specifications
13.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hepac (Darling Ingredients) Main Business Overview
13.9.5 Hepac (Darling Ingredients) Latest Developments
13.10 Huaian MDC Pharmaceutical
13.10.1 Huaian MDC Pharmaceutical Company Information
13.10.2 Huaian MDC Pharmaceutical Crude Heparin Product Portfolios and Specifications
13.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Huaian MDC Pharmaceutical Main Business Overview
13.10.5 Huaian MDC Pharmaceutical Latest Developments
13.11 Yantai Dongcheng Biochemicals
13.11.1 Yantai Dongcheng Biochemicals Company Information
13.11.2 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolios and Specifications
13.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Yantai Dongcheng Biochemicals Main Business Overview
13.11.5 Yantai Dongcheng Biochemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Crude Heparin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Crude Heparin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pig Intestine Mucosa Heparin
Table 4. Major Players of Bovine Heparin and Others
Table 5. Global Crude Heparin Sales byType (2020-2025) & (Tons)
Table 6. Global Crude Heparin Sales Market Share byType (2020-2025)
Table 7. Global Crude Heparin Revenue byType (2020-2025) & ($ million)
Table 8. Global Crude Heparin Revenue Market Share byType (2020-2025)
Table 9. Global Crude Heparin Sale Price byType (2020-2025) & (US$/Kg)
Table 10. Global Crude Heparin Sale by Application (2020-2025) & (Tons)
Table 11. Global Crude Heparin Sale Market Share by Application (2020-2025)
Table 12. Global Crude Heparin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Crude Heparin Revenue Market Share by Application (2020-2025)
Table 14. Global Crude Heparin Sale Price by Application (2020-2025) & (US$/Kg)
Table 15. Global Crude Heparin Sales by Company (2020-2025) & (Tons)
Table 16. Global Crude Heparin Sales Market Share by Company (2020-2025)
Table 17. Global Crude Heparin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Crude Heparin Revenue Market Share by Company (2020-2025)
Table 19. Global Crude Heparin Sale Price by Company (2020-2025) & (US$/Kg)
Table 20. Key Manufacturers Crude Heparin Producing Area Distribution and Sales Area
Table 21. Players Crude Heparin Products Offered
Table 22. Crude Heparin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Crude Heparin Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Crude Heparin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Crude Heparin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Crude Heparin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Crude Heparin Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Crude Heparin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Crude Heparin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Crude Heparin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 34. Americas Crude Heparin Sales Market Share by Country (2020-2025)
Table 35. Americas Crude Heparin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Crude Heparin Sales byType (2020-2025) & (Tons)
Table 37. Americas Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 38. APAC Crude Heparin Sales by Region (2020-2025) & (Tons)
Table 39. APAC Crude Heparin Sales Market Share by Region (2020-2025)
Table 40. APAC Crude Heparin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Crude Heparin Sales byType (2020-2025) & (Tons)
Table 42. APAC Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 43. Europe Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 44. Europe Crude Heparin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Crude Heparin Sales byType (2020-2025) & (Tons)
Table 46. Europe Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Crude Heparin Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Crude Heparin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Crude Heparin Sales byType (2020-2025) & (Tons)
Table 50. Middle East & Africa Crude Heparin Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Crude Heparin
Table 52. Key Market Challenges & Risks of Crude Heparin
Table 53. Key IndustryTrends of Crude Heparin
Table 54. Crude Heparin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Crude Heparin Distributors List
Table 57. Crude Heparin Customer List
Table 58. Global Crude Heparin SalesForecast by Region (2026-2031) & (Tons)
Table 59. Global Crude Heparin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 61. Americas Crude Heparin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Crude Heparin SalesForecast by Region (2026-2031) & (Tons)
Table 63. APAC Crude Heparin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 65. Europe Crude Heparin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Crude Heparin SalesForecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Crude Heparin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Crude Heparin SalesForecast byType (2026-2031) & (Tons)
Table 69. Global Crude Heparin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Crude Heparin SalesForecast by Application (2026-2031) & (Tons)
Table 71. Global Crude Heparin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Bioiberica Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 73. Bioiberica Crude Heparin Product Portfolios and Specifications
Table 74. Bioiberica Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Bioiberica Main Business
Table 76. Bioiberica Latest Developments
Table 77. Shenzhen Hepalink Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 78. Shenzhen Hepalink Crude Heparin Product Portfolios and Specifications
Table 79. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Shenzhen Hepalink Main Business
Table 81. Shenzhen Hepalink Latest Developments
Table 82. Sanofi Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Crude Heparin Product Portfolios and Specifications
Table 84. Sanofi Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Nanjing King-friend Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 88. Nanjing King-friend Crude Heparin Product Portfolios and Specifications
Table 89. Nanjing King-friend Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Nanjing King-friend Main Business
Table 91. Nanjing King-friend Latest Developments
Table 92.Fengrun BiologicalTechnology Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 93.Fengrun BiologicalTechnology Crude Heparin Product Portfolios and Specifications
Table 94.Fengrun BiologicalTechnology Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95.Fengrun BiologicalTechnology Main Business
Table 96.Fengrun BiologicalTechnology Latest Developments
Table 97. Aspen Oss Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 98. Aspen Oss Crude Heparin Product Portfolios and Specifications
Table 99. Aspen Oss Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Aspen Oss Main Business
Table 101. Aspen Oss Latest Developments
Table 102. Hebei Changshan Biochemical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 103. Hebei Changshan Biochemical Crude Heparin Product Portfolios and Specifications
Table 104. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Hebei Changshan Biochemical Main Business
Table 106. Hebei Changshan Biochemical Latest Developments
Table 107. Changzhou Qianhong Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 108. Changzhou Qianhong Crude Heparin Product Portfolios and Specifications
Table 109. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 110. Changzhou Qianhong Main Business
Table 111. Changzhou Qianhong Latest Developments
Table 112. Hepac (Darling Ingredients) Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 113. Hepac (Darling Ingredients) Crude Heparin Product Portfolios and Specifications
Table 114. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 115. Hepac (Darling Ingredients) Main Business
Table 116. Hepac (Darling Ingredients) Latest Developments
Table 117. Huaian MDC Pharmaceutical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 118. Huaian MDC Pharmaceutical Crude Heparin Product Portfolios and Specifications
Table 119. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 120. Huaian MDC Pharmaceutical Main Business
Table 121. Huaian MDC Pharmaceutical Latest Developments
Table 122. Yantai Dongcheng Biochemicals Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 123. Yantai Dongcheng Biochemicals Crude Heparin Product Portfolios and Specifications
Table 124. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 125. Yantai Dongcheng Biochemicals Main Business
Table 126. Yantai Dongcheng Biochemicals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Crude Heparin
Figure 2. Crude Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crude Heparin Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Crude Heparin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Crude Heparin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Crude Heparin Sales Market Share by Country/Region (2024)
Figure 10. Crude Heparin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pig Intestine Mucosa Heparin
Figure 12. Product Picture of Bovine Heparin and Others
Figure 13. Global Crude Heparin Sales Market Share byType in 2025
Figure 14. Global Crude Heparin Revenue Market Share byType (2020-2025)
Figure 15. Crude Heparin Consumed in UFH
Figure 16. Global Crude Heparin Market: UFH (2020-2025) & (Tons)
Figure 17. Crude Heparin Consumed in LMWH
Figure 18. Global Crude Heparin Market: LMWH (2020-2025) & (Tons)
Figure 19. Global Crude Heparin Sale Market Share by Application (2024)
Figure 20. Global Crude Heparin Revenue Market Share by Application in 2025
Figure 21. Crude Heparin Sales by Company in 2025 (Tons)
Figure 22. Global Crude Heparin Sales Market Share by Company in 2025
Figure 23. Crude Heparin Revenue by Company in 2025 ($ millions)
Figure 24. Global Crude Heparin Revenue Market Share by Company in 2025
Figure 25. Global Crude Heparin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Crude Heparin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Crude Heparin Sales 2020-2025 (Tons)
Figure 28. Americas Crude Heparin Revenue 2020-2025 ($ millions)
Figure 29. APAC Crude Heparin Sales 2020-2025 (Tons)
Figure 30. APAC Crude Heparin Revenue 2020-2025 ($ millions)
Figure 31. Europe Crude Heparin Sales 2020-2025 (Tons)
Figure 32. Europe Crude Heparin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Crude Heparin Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Crude Heparin Revenue 2020-2025 ($ millions)
Figure 35. Americas Crude Heparin Sales Market Share by Country in 2025
Figure 36. Americas Crude Heparin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Crude Heparin Sales Market Share byType (2020-2025)
Figure 38. Americas Crude Heparin Sales Market Share by Application (2020-2025)
Figure 39. United States Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Crude Heparin Sales Market Share by Region in 2025
Figure 44. APAC Crude Heparin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Crude Heparin Sales Market Share byType (2020-2025)
Figure 46. APAC Crude Heparin Sales Market Share by Application (2020-2025)
Figure 47. China Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Crude Heparin Sales Market Share by Country in 2025
Figure 55. Europe Crude Heparin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Crude Heparin Sales Market Share byType (2020-2025)
Figure 57. Europe Crude Heparin Sales Market Share by Application (2020-2025)
Figure 58. Germany Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 59.France Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Crude Heparin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Crude Heparin Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Crude Heparin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Crude Heparin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Crude Heparin in 2025
Figure 72. Manufacturing Process Analysis of Crude Heparin
Figure 73. Industry Chain Structure of Crude Heparin
Figure 74. Channels of Distribution
Figure 75. Global Crude Heparin Sales MarketForecast by Region (2026-2031)
Figure 76. Global Crude Heparin Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Crude Heparin Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Crude Heparin Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Crude Heparin Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Crude Heparin Revenue Market ShareForecast by Application (2026-2031)
